1.Epidemiological characteristics and inducing factors of gastric stump cancer.
Chinese Journal of Gastrointestinal Surgery 2018;21(5):498-501
Gastric stump cancer was initially defined as a carcinoma of the stomach occurring more than 5 years after surgery for gastric or duodenal benign disease. In recent years, as the number of total gastrectomy for benign disease has gradually decreased and the gastric cancer detection and operation rate have annually increased, residual recurrence of primary gastric cancer more than 10 years after gastric cancer surgery has also been considered as gastric stump cancer. The incidence of gastric stump cancer is increasing annually. The epidemiological characteristics of this form of cancer are also developing, and they show a higher incidence in males compared to females. The incidence has been affected following digestive tract reconstruction, and the risk increases in patients who undergo Billroth II( reconstruction. The interval of onset is related to the benign and malignant condition of primary disease, and the incidence increases after 10 years of early gastric cancer surgery. Lymph node metastasis pattern in gastric stump cancer is different from that in primary gastric cancer as the primary operation may destroy normal lymph flow. Many factors are known to cause gastric stump cancer, mainly duodenal gastric reflux, Helicobacter pylori infection, and gastric mucosal barrier dysfunction; however, the mechanism is not clear. It is expected to reduce the incidence of gastric stump cancer by taking precautionary measures against different inducements, which also has some guiding significance for the treatment and prognosis of gastric cancer.
Female
;
Gastrectomy
;
Gastric Stump
;
pathology
;
surgery
;
Gastroenterostomy
;
Humans
;
Incidence
;
Male
;
Neoplasm Recurrence, Local
;
Risk Factors
;
Stomach Neoplasms
;
epidemiology
;
etiology
;
surgery
2.Risk Factors for Recurrence of Ovarian Endometriosis in Chinese Patients Aged 45 and Over.
Zheng-Xing HE ; Ting-Ting SUN ; Shu WANG ; Hong-Hui SHI ; Qing-Bo FAN ; Lan ZHU ; Jin-Hua LENG ; Da-Wei SUN ; Jian SUN ; Jing-He LANG
Chinese Medical Journal 2018;131(11):1308-1313
BackgroundWhen considering the issue of recurrence, perimenopausal women may have more dilemma during management comparing with young women, for example, whether to retain the uterus and ovary during surgery, whether it is necessary to add adjuvant medicine treatment after operation, and there is no evidence for reference about using of gonadotropin-releasing hormone agonist. This study aimed to study the risk factors for the recurrence of ovarian endometriosis (EM) in patients aged 45 and over.
MethodsThis is a retrospective nested case-control study. We reviewed the medical records of patients aged over 45 years who underwent surgical treatments for ovarian EM from 1994 to 2014, in Peking Union Medical College Hospital of Chinese Academy of Medical Sciences. By following up to January 2016, 45 patients were found to have relapses and regarded as the recurrence group. The patients with no recurrence during the same follow-up period were randomly selected by the ratio of 1:4 as the nonrecurrence group (180 patients in total). Stratified Cox regression was used to analyze the risk factors of the recurrence.
ResultsUnivariate analysis showed that there was a significant difference in the postoperative treatment (the percentage of patients who received postoperative treatment in non-recurrence group and recurrence group, 23.9% vs. 40.0%, χ = 4.729, P = 0.030) and ovarian preservation (the percentage of patients who received surgery of ovarian preservation in non-recurrence group and recurrence group, 25.0 % vs. 44.4%, χ = 19.462, P < 0.001) between the nonrecurrence group and the recurrence group. There was no correlation between recurrence and the following factors including patient's age, menarche age, gravidity, parity, CA125 level, ovarian lesions, menopausal status, combined benign gynecological conditions (such as myoma and adenomyoma) and endometrial abnormalities, and surgical approach or surgical staging (all P > 0.05). Multivariate analysis indicated that whether to retain the ovary was the only independent risk factor of recurrence for patients aged 45 years and over with ovarian EM (odds ratio: 5.594, 95% confidence interval: 1.919-16.310, P = 0.002).
ConclusionOvarian preservation might be the only independent risk factor of recurrence for patients aged 45 years and over with ovarian EM.
Case-Control Studies ; Endometriosis ; epidemiology ; etiology ; Female ; Humans ; Male ; Middle Aged ; Neoplasm Recurrence, Local ; Odds Ratio ; Ovarian Neoplasms ; epidemiology ; etiology ; Ovary ; pathology ; Proportional Hazards Models ; Retrospective Studies ; Risk Factors
3.Clinical study of Marjolin's ulcer.
Soo Bong HAHN ; Dong Jun KIM ; Chang Hoon JEON
Yonsei Medical Journal 1990;31(3):234-241
Marjolin's ulcer is the malignant lesion which develops in a burn scar or chronic fistula. Due to the low prevalence of this lesion, there has been disagreement regarding its clinical features, methods of treatment, and prognosis. We evaluated 19 cases of patients who had been admitted to Severance Hospital from Jan. 1970 to Dec. 1985. The results were as follows: The previous lesion was a burn scar in 52% of the cases and a fistula of chronic osteomyelitis in 32%. The mean latent period was 31.5 years. The initial symptoms were increased pain (74%), discharge with foul odor (68%) and bleeding (58%). Upon histological examination, all of the cases were squamous cell carcinoma. The rate of metastasis at the time of diagnosis was 32%. Of the 16 patients treated by surgery, local recurrence was noted in 4 cases. Three of these cases were patients who had been treated by excision and split thickness skin graft. The time interval for local recurrence ranged from 6 months to 11 months (average 8.8 months). In conclusion, the squamous cell carcinoma of marjolin's ulcer seems to have a worse prognosis than other squamous cell carcinomas and it requires aggressive treatment. The burn scar or chronic fistula that occurs in elderly patients especially requires more adequate treatment and close observation.
Adult
;
Aged
;
Burns/complications
;
Carcinoma, Squamous Cell/*epidemiology/etiology/pathology/therapy
;
Case Report
;
Cicatrix/complications
;
Combined Modality Therapy
;
Female
;
Fistula/complications
;
Human
;
Korea/epidemiology
;
Male
;
Middle Age
;
Neoplasm Metastasis
;
Neoplasm Recurrence, Local/epidemiology
;
Osteomyelitis/complications
;
Prognosis
;
Skin Neoplasms/*epidemiology/etiology/pathology/therapy
4.Endoscopic and Oncologic Outcomes of Endoscopic Resection for Superficial Esophageal Neoplasm.
Do Hoon KIM ; Hwoon Yong JUNG ; Eun Jeong GONG ; Ji Young CHOI ; Ji Yong AHN ; Mi Young KIM ; Kwi Sook CHOI ; Jeong Hoon LEE ; Kee Don CHOI ; Ho June SONG ; Gin Hyug LEE ; Jin Ho KIM ; Young Soo PARK ; Seunghee BAEK
Gut and Liver 2015;9(4):470-477
BACKGROUND/AIMS: Endoscopic resection (ER) of superficial esophageal neoplasm (SEN) is a technically difficult procedure. We investigated the clinical outcomes of ER for SEN to determine its feasibility and effectiveness. METHODS: Subjects who underwent ER for SEN at Asan Medical Center between December 1996 and December 2010 were eligible. The clinical features of patients and tumors, histopathological characteristics, adverse events, ER results and survival were investigated. RESULTS: A total of 129 patients underwent ER for 147 SENs. En bloc resection (EnR) was performed in 118 lesions (80.3%). Complete resection (CR) was accomplished in 128 lesions (86.5%), and curative resection (CuR) was performed in 118 lesions (79.7%). The EnR, CR, and CuR rates were significantly greater in the endoscopic submucosal dissection group when compared to those in the endoscopic resection group. Adverse events occurred in 22 patients (17.1%), including bleeding (n=2, 1.6%), perforation (n=12, 9.3%), and stricture (n=8, 6.2%). Local tumor recurrence occurred in 2.0% of patients during a median follow-up of 34.8 months. The 5-year overall and disease-specific survival rates were 94.0% and 97.5%, respectively. CONCLUSIONS: ER is a feasible and effective method for the treatment of SEN as indicated by favorable clinical outcomes.
Aged
;
Aged, 80 and over
;
Disease-Free Survival
;
Dissection/*adverse effects/methods
;
Esophageal Neoplasms/pathology/*surgery
;
Esophageal Perforation/epidemiology/etiology
;
Esophageal Stenosis/epidemiology/etiology
;
Esophagoscopy/*adverse effects/methods
;
Female
;
Gastric Mucosa/surgery
;
Humans
;
Male
;
Middle Aged
;
Neoplasm Recurrence, Local/epidemiology
;
Postoperative Hemorrhage/epidemiology/etiology
;
Retrospective Studies
;
Treatment Outcome
5.Predictors of Recurrence after Thymoma Resection.
Mi Kyung BAE ; Chang Young LEE ; Jin Gu LEE ; In Kyu PARK ; Dae Joon KIM ; Woo Ick YANG ; Kyung Young CHUNG
Yonsei Medical Journal 2013;54(4):875-882
PURPOSE: Recurrence rate is considered a better measure of clinical outcomes after thymoma resection than overall survival due to the indolent behavior of thymomas. This study was designed to determine predictors of recurrence after thymoma resection. MATERIALS AND METHODS: A single-institution, retrospective study was performed, including 305 patients who had undergone thymoma resection between 1986 and 2009. RESULTS: Among 305 patients, recurrence was observed in 41 patients (13.4%). The recurrence rates were 0% (0/19), 6.3% (4/63), 4.2% (2/48), 18.6% (11/59) and 20.7% (24/116) for type A, AB, B1, B2 and B3 tumors, respectively. The recurrence rate according to Masaoka stage was 6.1% (8/132), 11.4% (13/114), 26.8% (11/41) and 50.0% (9/18) for stages I, II, III and IV, respectively. After univariate analysis, completeness of resection (R0 versus R1), World Health Organization (WHO) histologic type (A, AB, B1 versus B2, B3), Masaoka stage, and size of tumor (<8 cm versus > or =8 cm) demonstrated significant differences with freedom from recurrence. Upon multivariate analysis, Masaoka stage was the only independent predictor of recurrence. CONCLUSION: WHO histologic type, Masaoka stage, and size of tumor were associated with recurrence. Particularly, Masaoka stage was the only independent predictor of recurrence after thymoma resection.
Adolescent
;
Adult
;
Aged
;
Aged, 80 and over
;
Female
;
Follow-Up Studies
;
Humans
;
Male
;
Middle Aged
;
Multivariate Analysis
;
Neoplasm Recurrence, Local/epidemiology/*etiology
;
Retrospective Studies
;
Thymoma/mortality/*pathology/*surgery
;
Thymus Neoplasms/mortality/*pathology/*surgery
;
Young Adult
6.Option for different surgeries in treating small gastrointestinal stromal tumors.
Qian ZOU ; Lijuan FENG ; Miao OUYANG
Journal of Central South University(Medical Sciences) 2018;43(7):767-771
To explore the differences in biological characteristics for the small gastrointestinal stromal tumors and the incidence of complications and recurrence between the traditional surgical treatment and endoscopic treatment.
Methods: We collected the relevant clinical and pathological data from patients who were diagnosed as gastrointestinal stromal tumors with the diameter less than 2 cm by the Department of Pathology of Xiangya Hospital from January 2009 to December 2015. The complications and recurrence after the surgical treatment were analyzed.
Results: In patients with small gastrointestinal stromal tumors, the proportion of female was higher than that of male (male:female=1:1.69). The median age for patient with this disease was 49 years old and it was more common in middle-aged and elderly. Most lesions were found in the stomach, followed by the esophagus and the small intestine. The small gastrointestinal stromal tumors occurred in the colon and rectum were rare. There was 60.3% (47/78) patients with abdominal pain, 7.7% (6/78) patients with hematochezia or melena, and 98.7% (78/79) with small gastrointestinal stromal tumors' mitotic count ≤5/50 HPF. The positive rates for CD, CD34, DOG-1, actin-smooth, and S-100 were 98.7%, 86.1%, 82.3%, 31.6%, and 24.1%, respectively. Three patients occurred surgical complications, 2 suffered recurrence during the follow-up. There was no significant difference in the incidence of complications and recurrence between the traditional surgical treatment and endoscopic treatment (P>0.05).
Conclusion: Small gastrointestinal stromal tumors' malignant potential is low, and the recurrence and metastasis rate is low. Its biological behavior tends to be benign. The traditional surgical treatment and endoscopic treatment are both safe and effective for small gastrointestinal stromal tumor. Endoscopic treatment has the advantages in lower cost, shorter hospitalization time, and small trauma. Therefore, endoscopic treatment could be the first choice for small GIST resection under the condition of mature endoscopic technology.
Aged
;
Endoscopy, Gastrointestinal
;
Female
;
Gastrointestinal Hemorrhage
;
etiology
;
Gastrointestinal Neoplasms
;
complications
;
pathology
;
surgery
;
Gastrointestinal Stromal Tumors
;
complications
;
pathology
;
surgery
;
Humans
;
Incidence
;
Male
;
Middle Aged
;
Neoplasm Recurrence, Local
;
Postoperative Complications
;
epidemiology
;
Retrospective Studies
;
Tumor Burden
7.Risk factors for early recurrence after surgical resection for hepatocellular carcinoma.
Ui Jun PARK ; Yong Hoon KIM ; Koo Jeong KANG ; Tae Jin LIM
The Korean Journal of Hepatology 2008;14(3):371-380
BACKGROUND/AIMS: Early recurrence (ER) after liver resection is one of the most important factors impacting the prognosis and survival of patients with hepatocellular carcinoma (HCC). This study aimed to identify the factors associated with ER after curative hepatic resection for HCC. METHODS: From the July 2000 to July 2006, 144 patients underwent hepatic resection for HCC at a single institution. After excluding those with ruptured HCC, combined or mixed HCC, and who died during admission, 116 patients were analyzed. Patients with ER (defined as within 1 year) were compared with those who remained free of disease for more than 1 year. Various clinical characteristics including tumor and operative factors were evaluated to determine the factors predicting postoperative ER using univariate and multivariate analyses. RESULTS: ER occurred in 51 patients (44%). In the univariate analysis, tumor size (P=0.001), microvascular invasion (P=0.003), portal vein invasion (P=0.001), TNM stage (P=0.010), serum levels of alpha-fetoprotein (AFP) (P=0.002) and aspartate aminotransferase (AST) (P=0.011), and operative time (P=0.033) were significantly associated with ER. AFP and AST were the independent predictors of ER in the multivariate analysis (P<0.05). CONCLUSIONS: Preoperative serum AFP and AST levels were the independent risk factors for ER after surgical resection for HCC. Close postoperative surveillance is recommended for early detection of recurrence and additional treatments in patients with these factors.
Adult
;
Aged
;
Carcinoma, Hepatocellular/etiology/mortality/*surgery
;
Female
;
Humans
;
Liver Neoplasms/etiology/mortality/*surgery
;
Male
;
Middle Aged
;
Multivariate Analysis
;
Neoplasm Invasiveness
;
Neoplasm Recurrence, Local/*epidemiology
;
Neoplasm Staging
;
Predictive Value of Tests
;
Retrospective Studies
;
Risk Factors
;
Survival Rate
;
Time Factors
;
alpha-Fetoproteins/analysis